• , FDA Development White Paper

    AAPS PharmSciTech, Vol. 16, No. 3

    Research Article

    Publication
    The Influence of Secondary Processing on the Structural Relaxation Dynamics of Fluticasone Propionate
  • , FDA Development White Paper

    Pharmaceutical Research, Vol. 25, No. 7,

    Research Paper

    Case Studies
    The Role of Fines in the Modification of the Fluidization and Dispersion Mechanism Within Dry Powder Inhaler Formulations
  • , FDA Development White Paper

    Pharm Res (2012) 29:994–1006

    Research Paper

    Publication
    Investigation into the Influence of Primary Crystallization Conditions on Dry Powder Inhaler Formulations
  • , FDA Development White Paper

    UniDose Dissolution

    UniDose

    Case Studies
    Novel aerosol collection apparatus for dissolution testing of orally inhaled drug products
  • , FDA Development White Paper

    Value Creation by Disruptive Innovation

    Disruptive Innovation Overview

    Documentation
    Nanopharm is creating value for our clients through disruptive innovation in respiratory product development.
  • , FDA Development White Paper

    Your alternative solution to clinical end-point bioequivalence

    FDA Development White Paper

    Documentation,Publication
    SmartTrack™ offers the alternative solution to the updated FDA approval process for generic respiratory products.